Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy

This publication has 15 references indexed in Scilit:

• A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis: An NCI Canada Clinical Trials Group Phase III Trial
  European Journal Of Cancer, 1993
• A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy
  European Journal Of Cancer, 1992
• A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis
  European Journal Of Cancer, 1992
• Serotonin Antagonists: A New Class of Antiemetic Agents
  JNCI Journal of the National Cancer Institute, 1991
• 5-Year Results of Cisplatin and Fluorouracil Infusion in Head and Neck Cancer
  JAMA Otolaryngology–Head & Neck Surgery, 1991
• High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting
  Investigational New Drugs, 1990
• Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis
  New England Journal of Medicine, 1990
• Anticipatory nausea and vomiting: Does it remain a significant clinical problem?
  Cancer, 1988
• The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694
  British Journal of Cancer, 1988
• Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer
  Cancer, 1988